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Percutaneous radiofrequency ablation: A novel
treatment of facial venous malformation
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Seoul, Republic of Korea
We performed radiofrequency ablation to treat a symptomatic facial venous malformation of a 24-year-old woman
under ultrasound scan-guidance. The 20.25-cm sized original facial venous malformation in her right cheek
markedly reduced without any scar formation and was grossly not visible after 1 month of the procedure. In the
3-month follow-up magnetic resonance imaging, original venous malformation reduced in volume to 5.40 cm.
Radiofrequency ablation may provide an alternative treatment for facial venous malformations. ( J Vasc Surg 2009;
50:424-7.)CASE REPORT
A 24-year-old woman had a large palpable lesion in her
right perimandibular area since her childhood. The lesion slowly
increased in size as she grew older causing cosmetic problems.
She complained of intermittent sensation of swelling but the
lesion did not cause any pain. Physical examination revealed a
large, easily compressible, swelling lesion which expanded in
size during valsalva maneuver (Fig 1). The neck computed
tomography (CT) she had performed initially showed a 4.1-cm
sized delay enhancing well marginated venous malformation
(VM) located inferior to the right parotid gland. For further
evaluation, she underwent a neck magnetic resonance imaging
(MRI) scan in 1 month which showed high signal intensity VM
on T2 weighted image with no change in size and location as the
previous neck CT (Fig 2). The final diagnosis was made as VM
located lateral to the internal jugular vein and carotid artery in
the right perimandibular area inferior to the parotid gland
extending to the superficial neck. Sclerotherapy with ethanol or
surgical excision was initially considered as treatment but the
patient refused due to complications such as skin necrosis,
neural toxicity, and scar formation. We had successful experi-
ences in ablating benign thyroid nodules abutting the carotid
artery and recurrent laryngeal nerve, therefore, we were able to
plan radiofrequency ablation (RFA) of the VM located near the
carotid artery and the cervical branch of facial nerve. Before the
procedure, informed consent was obtained. RFA was performed
percutaneously under real time ultrasound (US) scan-guidance
on an outpatient basis. The patient was placed in supine position
with the neck extended and tilted to the left. Two grounding
pads were attached to both thighs. Under US scan examination,
the operator determined the approach route for the electrode.
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424Two percent lidocaine hydrochloride (KwangMyung, Seoul,
Korea) was used for local anesthesia at the puncture site. The
skin was not incised in order to prevent unnecessary scar forma-
tion. An electrode was inserted along the oblique axis of the
VM. The RFA procedure was performed by one of the authors
(H.K.K.). We used a 200 W radiofrequency (RF)-current (480-
kHz) generator (CTRF-220; Valleylab, Boulder, Colo) and
internally cooled electrode (Cool-tip RF system, Valleylab), a
17-gauge straight needle type with a 1-cm active tip. All US scan
procedures were performed with the same transducer using the
free-hand technique.1 After inserting the electrode into the VM,
we confirmed that the entire segment of the active tip of the
electrode was completely included in the VM by measuring the
length along the shaft of the electrode from its tip. We placed
the electrode in the center of the VM. After the VM was
conceptually compartmentalized, each compartment was ab-
lated sequentially by moving the tip of the electrode to the left
and the right or forwards and backwards. The extent of the
ablated area was presumed by the echogenic change around the
electrode. When the transient echogenic change appeared, ap-
plication of RF energy stopped due to increased electric resis-
tance and the electrode tip was moved to an untreated area after
the generator was switched off. In this way, ablation was termi-
nated when all units of the VM had changed to transient
hyperechoic zones (Fig 3). The power output of RF energy was
set maximally and moved from 50 W to 80 W in 1-cm active tip
electrode under impedance control mode. With local anesthe-
sia, the patient tolerated the pain well until the end of the
procedure. The total ablation time was 20 minutes including
time for lesion targeting. At the end of the procedure, the
patient was discharged after 1 hour of close observation.
The patient followed-up with US scan in 1 month and an
MRI in 3 months. Follow-up US scan showed remarkable size
reduction of the VM from 4.1 cm to 1.5 cm. The volume of the
VM was reduced from 20.25 cm to 5.4 cm on MRI by using an
off-line workstation (AquariusNET, v 1.8.0.3; TeraRecon, San
Mateo, Calif). Without any remaining scar, the protruded VM
below the parotid gland grossly disappeared in 1 month fol-
low-up after RFA (Fig 1).
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VM is defined as a simple malformation with slow
flow and abnormal venous network. It is characterized by
soft, compressible, non-pulsatile tissue mass. It tends to
grow over time in proportion to the growth of the pa-
tient.2 Forty percent of VMs in adults are found in the head
and neck area.2,3 Our patient had a VM in the perimandibular
area, but additional related symptoms or dysfunctions were
not found except esthetic disfiguration, which was her main
complaint.
Treatment of VMs is indicated when they cause
aesthetic problems, pain, or functional problems. Com-
monly known treatment options of VMs are sclerother-
apy, laser therapy, and surgical resection. Sclerotherapy
is the most widely used treatment option for VMs. It is
performed by percutaneously inserting a needle into the
nidus and injecting a sclerosing substance. However,
several complications are reported due to the use of
ethanol, including cutaneous necrosis and neural toxic-
Fig 1. A photo of the venousmalformation in the right check area
before (A) and after (B) radiofrequency ablation (RFA). A large
protruding mass (arrows) is prominently seen before RFA and
disappears after RFA.ity. Also, many patients feel pain after the procedure andseveral sessions are necessary for complete cure with a
time delay of 1-3 months between each session.4,5 Re-
cently, foam sclerotherapy is used which has advantages
over liquid sclerotherapy by using smaller amounts of
sclerosing agents with higher therapeutic effects. How-
ever, complications such as pain, swelling, and skin ne-
crosis still remains.6 Laser therapy can be useful in very
superficial forms of VMs. Satisfactory results with mini-
mal scarring have been reported, but recurrences and
repeated treatments are common.2 The most definitive
treatment of VM is by surgical excision, but only super-
ficial small lesions can be considered. Attempts to excise
large VMs usually cause significant morbidity and surgi-
cal resection always leaves a large scar.2,7
RFA is a minimally invasive, safe procedure. A needle
electrode (14-17.5 gauge) with an insulated shaft and a
non-insulated distal tip is inserted into the lesion under
imaging guidance. In radiologic practice, it is used widely
for the treatment of unresectable malignant tumors and
several benign lesions.1,8,9 Recently, RFA has been at-
tempted as another alternative treatment for VMs. RFA for
treatment of symptomatic low-flow VMs has been recently
published by van der Linden et al.10 In this report, a total of
3 patients (all reportedly diagnosed with capillary venous
malformation, all in the lower extremities) were treated
with RFA. The paper reported no complications. All pa-
tients were reported to be treated successfully, although 1
patient had symptomatic recurrence after a year. However,
until now, to the best of our knowledge, there has been no
reported study on RFA of VMs above the neck.
The location of the VM in our patient was in the
right perimandibular area where RFA is generally not
considered as a treatment due to surrounding important
structures such as the carotid artery and the facial nerve.
To overcome this situation, we used an internally cooled
electrode which has a 1-cm active tip. Ablation was
performed by shifting the 1-cm active tip within the VM
under real-time US scan-guidance. Because all the areas
ablated turns echogenic on US scan, we could distin-
guish between the non-ablated and ablated areas and
treatment of over 90% of the patient’s facial VM was
possible. Unlike ablating deep located organs such as the
liver, real-time US scan-guidance is possible for superfi-
cially located lesions. We named this technique as the
“moving tip technique”. This technique has been re-
ported to be safe and effective on benign thyroid nodules
in close proximity to the carotid artery and the recurrent
laryngeal nerve. When setting the generator on imped-
ance mode, this technique induces hot bubbles above the
cell-cidal temperature around the electrode and these
hot bubbles are monitored throughout the whole proce-
dure by real-time US scan. Therefore, although the
target lesion is surrounded by important structures, RFA
can be safely performed. The current of the generator is
automatically blocked when the impedance of the sur-
rounding structures increase due to induced hot bub-
bles. When this occurs, the electrode is re-inserted into a
different site of the lesion and in this manner treatment
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genic changes caused by the hot bubbles. There is no size
Fig 2. Axial and coronal magnetic resonance (MR) ima
cheek (arrows). Axial and coronal MR images (C, D) 3
shrunk with dark signal fibrous code in the center.limit when using this “moving tip technique” if real-timeUS scan is possible and we could ablate a VM of about
4.1 cm in size. As reported in previous RFA of thyroid
, B) before RFA show a hyper-intense mass in the right
hs after RFA shows that the vascular mass has markedlyges (A
montnodules, the time taken for the generator to shut off is
vascular mass could be ablated.
JOURNAL OF VASCULAR SURGERY
Volume 50, Number 2 Kim et al 427less than 3 seconds of ablation and the hot bubbles can
be controlled to be within the VM by US scan. There-
fore, the patient feels less pain during the procedure. The
size of the mass was reduced immediately when high
frequency heat was applied under US scan-guidance. We
presume this immediate reduction in size is caused by
shrinkage of the mass as the blood within the dilated
vessels leaks out due to denaturation of proteins when
heat is conducted through the vascular septa of the VM.
The procedure took about 20 minutes including the time
taken for targeting. Because a 17 gauge needle is inserted
without surgical incision, there was no concern for post-
procedure scar formations. She could continue her usual
day to day life immediately after the procedure.
In summary, we report a case of a 4.1-cm sized cavern-
ous malformation located above the neck which was suc-
cessfully treated by RFA. In the near future, RFA with
real-time US scan-guidance may provide an alternative
treatment for low flow VMs with more advanced therapeu-
tic effects and less morbidity.
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747-50.Fig 3. Ultrasound (US) scan image of the venous malformation
(VM) (A) at the time of radiofrequency ablation (RFA) shows the
radiofrequency (RF) electrode (arrowheads) in the center of the
hypoechoic mass (B). During ablation, echogenic areas (arrows)
around the electrode caused by hot microbubbles are well distin-
guished from the untreated lesion (C). In this way, most of theSubmitted Jan 28, 2009; accepted Mar 8, 2009.
